ArticlePloS one2025
Hematocrit in the first 2 hours of life and short-term outcomes in very preterm infants: A secondary analysis from a prospective cohort study.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPreterm birth, particularly very preterm birth (before 32 weeks of gestation), is a leading cause of neonatal morbidity and mortality. The early neonatal period is critical for preterm infants, with hematocrit levels serving as a important physiological indicator. We aimed to assess the relationship hematocrit in the first 2 hours of life and Short Outcomes in very preterm infants.
methodsThe research was a prospective cohort study completed by Dongli Song et al. We acquired data from the DATA DRYAD website and utilized exclusively for secondary analysis. From January 2008 to April 2014, data were gathered prospectively from eligible infants at the Santa Clara Valley Medical Center. The main outcomes included any Intraventricular Hemorrhage (IVH), any Retinopathy of Prematurity (ROP), Necrotizing Enterocolitis (NEC), chronic lung disease (CLD), and late-onset sepsis (LOS). Secondary outcomes were any intubation and any transfusion. We used multivariable logistic regression analyses to calculate adjusted odd ratio (OR) with 95% CI.
resultsThis study included 312 patients in total. Hematocrit in the first 2 hours of life, considered as a continuous variable, was significantly associated with short-term outcomes in univariate analyses (P < 0.05). After adjusting for GA, BW, and sex, only any ROP, any intubation, and any transfusion were statistically significant. With adjustments for multiple factors, the odds ratios for any ROP and any transfusion in infants whose Hematocrit was 45 or more in the first two hours of life, compared to those with an HCT less than 45 were 0.43 (95% CI, 0.19 ~ 0.97, p = 0.043) and 0.29 (95% CI, 0.12 ~ 0.7, p = 0.006).
conclusionsOur study shows that higher HCT in the first 2 hours of life was statistically significant association with decreased ROP and blood transfusion in very preterm infants. Further clinical trials are necessary to confirm and validate this association.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.